Page last updated: 2024-09-03

omega-n-methylarginine and Foot Diseases

omega-n-methylarginine has been researched along with Foot Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Calapai, G; Caputi, AP; Cuzzocrea, S; Nava, F; Zingarelli, B	1

Other Studies

1 other study(ies) available for omega-n-methylarginine and Foot Diseases

Article	Year
Zymosan-activated plasma induces paw oedema by nitric oxide and prostaglandin production. Life sciences, 1997, Volume: 60, Issue:3 Topics: Animals; Arginine; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Edema; Enzyme Inhibitors; Foot Diseases; Hemoglobins; Indomethacin; Inflammation; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Prostaglandins; Rats; Zymosan	1997

Article

Year

Zymosan-activated plasma induces paw oedema by nitric oxide and prostaglandin production.

Life sciences, 1997, Volume: 60, Issue:3

Topics: Animals; Arginine; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Edema; Enzyme Inhibitors; Foot Diseases; Hemoglobins; Indomethacin; Inflammation; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Prostaglandins; Rats; Zymosan

1997